Astrazeneca AB v. Apotex Inc.
Court headnote
Astrazeneca AB v. Apotex Inc. Court (s) Database Federal Court of Appeal Decisions Date 2004-06-09 Neutral citation 2004 FCA 224 File numbers A-29-04 Decision Content Date: 20040609 Docket: A-29-04 Citation: 2004 FCA 224 CORAM: LINDEN J.A. SHARLOW J.A. MALONE J.A. BETWEEN: ASTRAZENECA AB and ASTRAZENECA CANADA INC. Appellants (Applicants) and APOTEX INC. and THE MINISTER OF HEALTH Respondents (Respondents) Heard at Toronto, Ontario, on June 9, 2004. Judgment delivered from the Bench at Toronto, Ontario, on June 9, 2004. REASONS FOR JUDGMENT OF THE COURT BY: SHARLOW J.A. Date: 20040609 Docket: A-29-04 Citation: 2004 FCA 224 CORAM: LINDEN J.A. SHARLOW J.A. MALONE J.A. BETWEEN: ASTRAZENECA AB and ASTRAZENECA CANADA INC. Appellants (Applicants) and APOTEX INC. and THE MINISTER OF HEALTH Respondents (Respondents) REASONS FOR JUDGMENT OF THE COURT (Delivered from the Bench at Toronto, Ontario, on June 9, 2004) SHARLOW J.A. [1] Having heard the representations and read the submissions of both parties, we are not persuaded that there is any basis for distinguishing this case from Merck Frosst Canada Inc. et al. v. Apotex et al. (1999), 240 N.R. 195 (F.C.A.), Pfizer Canada Inc. v. Nu-Pharm Inc.; Pfizer Canada Inc. v. Apotex Inc. (2001), 11 C.P.R. (4th) 245 (F.C.A.), Novartis Pharmaceuticals Canada Inc. v. Rhoxalpharma Inc. (2001), 16 C.P.R. (4th) 188 (F.C.A.) and Novartis AG v. Apotex Inc. (2002), 22 C.P.R. (4th) 450 (F.C.A.). We are persuaded that this appeal is moot, and that there …
Read full judgment
Astrazeneca AB v. Apotex Inc. Court (s) Database Federal Court of Appeal Decisions Date 2004-06-09 Neutral citation 2004 FCA 224 File numbers A-29-04 Decision Content Date: 20040609 Docket: A-29-04 Citation: 2004 FCA 224 CORAM: LINDEN J.A. SHARLOW J.A. MALONE J.A. BETWEEN: ASTRAZENECA AB and ASTRAZENECA CANADA INC. Appellants (Applicants) and APOTEX INC. and THE MINISTER OF HEALTH Respondents (Respondents) Heard at Toronto, Ontario, on June 9, 2004. Judgment delivered from the Bench at Toronto, Ontario, on June 9, 2004. REASONS FOR JUDGMENT OF THE COURT BY: SHARLOW J.A. Date: 20040609 Docket: A-29-04 Citation: 2004 FCA 224 CORAM: LINDEN J.A. SHARLOW J.A. MALONE J.A. BETWEEN: ASTRAZENECA AB and ASTRAZENECA CANADA INC. Appellants (Applicants) and APOTEX INC. and THE MINISTER OF HEALTH Respondents (Respondents) REASONS FOR JUDGMENT OF THE COURT (Delivered from the Bench at Toronto, Ontario, on June 9, 2004) SHARLOW J.A. [1] Having heard the representations and read the submissions of both parties, we are not persuaded that there is any basis for distinguishing this case from Merck Frosst Canada Inc. et al. v. Apotex et al. (1999), 240 N.R. 195 (F.C.A.), Pfizer Canada Inc. v. Nu-Pharm Inc.; Pfizer Canada Inc. v. Apotex Inc. (2001), 11 C.P.R. (4th) 245 (F.C.A.), Novartis Pharmaceuticals Canada Inc. v. Rhoxalpharma Inc. (2001), 16 C.P.R. (4th) 188 (F.C.A.) and Novartis AG v. Apotex Inc. (2002), 22 C.P.R. (4th) 450 (F.C.A.). We are persuaded that this appeal is moot, and that there is no sound basis for hearing the appeal despite its mootness. [2] This motion to dismiss the appeal should be allowed with costs. "Karen R. Sharlow" J.A. FEDERAL COURT OF APPEAL NAMES OF COUNSEL AND SOLICITORS OF RECORD DOCKET: A-29-04 STYLE OF CAUSE: ASTRAZENECA AB and ASTRAZENECA CANADA INC. Appellants (Applicants) and APOTEX INC. and THE MINISTER OF HEALTH Respondents (Respondents) PLACE OF HEARING: TORONTO, ONTARIO DATE OF HEARING: JUNE 9, 2004 REASONS FOR JUDGMENT OF THE COURT: (LINDEN, SHARLOW & MALONE JJ.A) DELIVERED FROM THE BENCH BY: SHARLOW J.A. APPEARANCES: Mr. Gunars Gaikis Ms. Kavita Ramamoorthy FOR THE APPELLANTS Mr. Andrew Brodkin FOR THE RESPONDENT, APOTEX INC. SOLICITORS OF RECORD: Smart & BiggarLLP Toronto, Ontario FOR THE APPELLANTS Goodmans LLP Toronto, Ontario FOR THE RESPONDENT, APOTEX INC.
Source: decisions.fca-caf.gc.ca